chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching at injection site; Pain at injection site; Injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Injection site swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 027A21A) for COVID-19 vaccination.     No relevant medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE, ATORVASTATIN, VALACYCLOVIR [VALACICLOVIR] and LOSARTAN for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Injection site swollen). At the time of the report, VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Injection site swollen) outcome was unknown.            Patient took extra strength Tylenol but the pain reoccurred after 2-3 hours. Patient also applied ice to the swollen arm.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up information received on 10-May-2021 contain no new information.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Injection site nodule, Pain in extremity, Throat irritation
Clinical narrative: Her arm was pink about 4 inches round below the injection site; She felt weird (she felt like her body was getting sick); Throat was scratchy; fatigued; Little swollen at the injection site; Her arm hurt like after getting the flu shot; Bump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm hurt like after getting the flu shot), INJECTION SITE NODULE (Bump at the injection site), FEELING ABNORMAL (She felt weird (she felt like her body was getting sick)), THROAT IRRITATION (Throat was scratchy) and FATIGUE (fatigued) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Her arm hurt like after getting the flu shot), INJECTION SITE NODULE (Bump at the injection site) and VACCINATION SITE SWELLING (Little swollen at the injection site). On 07-Apr-2021, the patient experienced FEELING ABNORMAL (She felt weird (she felt like her body was getting sick)), THROAT IRRITATION (Throat was scratchy) and FATIGUE (fatigued). On 11-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Her arm was pink about 4 inches round below the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 04-Apr-2021, PAIN IN EXTREMITY (Her arm hurt like after getting the flu shot), INJECTION SITE NODULE (Bump at the injection site) and VACCINATION SITE SWELLING (Little swollen at the injection site) had resolved. On 10-Apr-2021, FEELING ABNORMAL (She felt weird (she felt like her body was getting sick)), THROAT IRRITATION (Throat was scratchy) and FATIGUE (fatigued) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Her arm was pink about 4 inches round below the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Her arm was pink about 4 inches round below the injection site; She felt weird (she felt like her body was getting sick); Throat was scratchy; fatigued; Little swollen at the injection site; Her arm hurt like after getting the flu shot; Bump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm hurt like after getting the flu shot), INJECTION SITE NODULE (Bump at the injection site), FEELING ABNORMAL (She felt weird (she felt like her body was getting sick)), THROAT IRRITATION (Throat was scratchy) and FATIGUE (fatigued) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Her arm hurt like after getting the flu shot), INJECTION SITE NODULE (Bump at the injection site) and VACCINATION SITE SWELLING (Little swollen at the injection site). On 07-Apr-2021, the patient experienced FEELING ABNORMAL (She felt weird (she felt like her body was getting sick)), THROAT IRRITATION (Throat was scratchy) and FATIGUE (fatigued). On 11-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Her arm was pink about 4 inches round below the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 04-Apr-2021, PAIN IN EXTREMITY (Her arm hurt like after getting the flu shot), INJECTION SITE NODULE (Bump at the injection site) and VACCINATION SITE SWELLING (Little swollen at the injection site) had resolved. On 10-Apr-2021, FEELING ABNORMAL (She felt weird (she felt like her body was getting sick)), THROAT IRRITATION (Throat was scratchy) and FATIGUE (fatigued) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Her arm was pink about 4 inches round below the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: He is 17 and received the 1st dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (He is 17 and received the 1st dose of the vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (He is 17 and received the 1st dose of the vaccine). On 06-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (He is 17 and received the 1st dose of the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   This case was linked to MOD-2021-114368 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Fatigue, Nasal congestion, Rhinorrhoea
Clinical narrative: difficulty breathing; extremely congested; nose is constantly running; feels like chest is full of fluid; sleepy for one day; really tired; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid) and SOMNOLENCE (sleepy for one day) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Colon cancer. Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN, FLUOXETINE HYDROCHLORIDE (PROZAC), COLECALCIFEROL (VIT D [COLECALCIFEROL]) and LISINOPRIL for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid), SOMNOLENCE (sleepy for one day) and FATIGUE (really tired). At the time of the report, DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid), SOMNOLENCE (sleepy for one day) and FATIGUE (really tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: difficulty breathing; extremely congested; nose is constantly running; feels like chest is full of fluid; sleepy for one day; really tired; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid) and SOMNOLENCE (sleepy for one day) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Colon cancer. Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN, FLUOXETINE HYDROCHLORIDE (PROZAC), COLECALCIFEROL (VIT D [COLECALCIFEROL]) and LISINOPRIL for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid), SOMNOLENCE (sleepy for one day) and FATIGUE (really tired). At the time of the report, DYSPNOEA (difficulty breathing), NASAL CONGESTION (extremely congested), RHINORRHOEA (nose is constantly running), CHEST DISCOMFORT (feels like chest is full of fluid), SOMNOLENCE (sleepy for one day) and FATIGUE (really tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to animal (Cat).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced DYSPNOEA (Difficulty breathing). At the time of the report, DYSPNOEA (Difficulty breathing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment was provided.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Influenza like illness, Paraesthesia, Pruritus
Clinical narrative: He felt a little tired.; Mouth and nose felt tingly/itchy; Throat closing; Mouth and nose felt tingly/itchy; Fever; Chills; Flu-ish; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-ish), PRURITUS (Mouth and nose felt tingly/itchy), THROAT TIGHTNESS (Throat closing), PARAESTHESIA (Mouth and nose felt tingly/itchy) and PYREXIA (Fever) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021 at 2:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-ish), PYREXIA (Fever) and CHILLS (Chills). On 14-Apr-2021, the patient experienced PRURITUS (Mouth and nose felt tingly/itchy), THROAT TIGHTNESS (Throat closing) and PARAESTHESIA (Mouth and nose felt tingly/itchy). On an unknown date, the patient experienced FATIGUE (He felt a little tired.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of UNK, tid. On 14-Apr-2021, INFLUENZA LIKE ILLNESS (Flu-ish), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, PRURITUS (Mouth and nose felt tingly/itchy), THROAT TIGHTNESS (Throat closing), PARAESTHESIA (Mouth and nose felt tingly/itchy) and FATIGUE (He felt a little tired.) outcome was unknown.            No relevant concomitant medications were reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Throat tightness
Clinical narrative: He felt a little tired.; Mouth and nose felt tingly/itchy; Throat closing; Mouth and nose felt tingly/itchy; Fever; Chills; Flu-ish; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-ish), PRURITUS (Mouth and nose felt tingly/itchy), THROAT TIGHTNESS (Throat closing), PARAESTHESIA (Mouth and nose felt tingly/itchy) and PYREXIA (Fever) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021 at 2:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-ish), PYREXIA (Fever) and CHILLS (Chills). On 14-Apr-2021, the patient experienced PRURITUS (Mouth and nose felt tingly/itchy), THROAT TIGHTNESS (Throat closing) and PARAESTHESIA (Mouth and nose felt tingly/itchy). On an unknown date, the patient experienced FATIGUE (He felt a little tired.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of UNK, tid. On 14-Apr-2021, INFLUENZA LIKE ILLNESS (Flu-ish), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, PRURITUS (Mouth and nose felt tingly/itchy), THROAT TIGHTNESS (Throat closing), PARAESTHESIA (Mouth and nose felt tingly/itchy) and FATIGUE (He felt a little tired.) outcome was unknown.            No relevant concomitant medications were reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: testing Positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (testing Positive for Covid) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 027L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced COVID-19 (testing Positive for Covid). At the time of the report, COVID-19 (testing Positive for Covid) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test: positive (Positive) Positive. On 18-Mar-2021, SARS-CoV-2 test: negative (Negative) Negative. On 22-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. On 08-Apr-2021, SARS-CoV-2 test: negative (Negative) Negative. On 12-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medication reported.  No treatment information was provided.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of headache, pyrexia (fever) and myalgia (muscle pain) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 081B21A) for COVID-19 immunization. No medical history reported. On Mar 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 12, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 12, 2021, patient experienced headache, pyrexia (fever) and myalgia (muscle pain). The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency; and ibuprofen, at an unspecified dose and frequency. At the time of the report, headache, pyrexia (fever) and myalgia (muscle pain) outcome: unknown. No relevant concomitant medications reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Pyrexia
Clinical narrative: Cough; Fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough) and PYREXIA (Fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 647A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced COUGH (Cough) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COUGH (Cough) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Muscular weakness, Pain in extremity
Clinical narrative: legs felt like jello; pressure on chest lasted for 4-5 hours; sore arm; This spontaneous case was reported by a pharmacist and describes the occurrence of MUSCULAR WEAKNESS (legs felt like jello), CHEST DISCOMFORT (pressure on chest lasted for 4-5 hours) and PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (legs felt like jello), CHEST DISCOMFORT (pressure on chest lasted for 4-5 hours) and PAIN IN EXTREMITY (sore arm). At the time of the report, MUSCULAR WEAKNESS (legs felt like jello), CHEST DISCOMFORT (pressure on chest lasted for 4-5 hours) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Developed a throbbing in injected arm.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Developed a throbbing in injected arm.) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Diabetes. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and TRAMADOL for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced PAIN (Developed a throbbing in injected arm.). At the time of the report, PAIN (Developed a throbbing in injected arm.) had resolved.            Concomitant medications also included: high blood pressure medications and diabetes medication.  No treatment was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-076448 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Additional information received: Updated event outcome.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076448:1 dose
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19 after receiving dose 1of the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after receiving dose 1of the Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after receiving dose 1of the Moderna vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after receiving dose 1of the Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: chills; body aches; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (body aches) and PYREXIA (low grade fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced CHILLS (chills), MYALGIA (body aches) and PYREXIA (low grade fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills), MYALGIA (body aches) and PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Magnetic resonance imaging
Clinical narrative: Feeling dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Feeling dizziness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included NO ADVERSE EVENT (No medical history reported).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Feeling dizziness). At the time of the report, DIZZINESS (Feeling dizziness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Magnetic resonance imaging: doctor did not find anything (normal) Other.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Additional information received: Updated event outcome from unknown to recovered for the reported event. Patient had declined further follow-up.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Passed 42 days mark to receive the 2nd dose; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Passed 42 days mark to receive the 2nd dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Passed 42 days mark to receive the 2nd dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Passed 42 days mark to receive the 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported.  No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Contusion, Pain, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: missed the 42 day window for the second moderna covid-19; Tested postive for COVID / Bamlanivab infusion after testing positive for COVID-19; bruise; I had an old scare that stung; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruise), PAIN (I had an old scare that stung), COVID-19 (Tested postive for COVID / Bamlanivab infusion after testing positive for COVID-19) and PRODUCT DOSE OMISSION ISSUE (missed the 42 day window for the second moderna covid-19) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced CONTUSION (bruise) and PAIN (I had an old scare that stung). On 22-Feb-2021, the patient experienced COVID-19 (Tested postive for COVID / Bamlanivab infusion after testing positive for COVID-19). On 17-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed the 42 day window for the second moderna covid-19). The patient was treated with BAMLANIVIMAB for COVID-19, at an unspecified dose and frequency. On 01-Apr-2021, CONTUSION (bruise) and PAIN (I had an old scare that stung) had resolved. At the time of the report, COVID-19 (Tested postive for COVID / Bamlanivab infusion after testing positive for COVID-19) and PRODUCT DOSE OMISSION ISSUE (missed the 42 day window for the second moderna covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, SARS-CoV-2 test: positive (Positive) Nasopharyngeal PCR- positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Lab test added, treatment received date added in I narrative. On 17-May-2021: Concomitant medication, new events were added
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Condition aggravated, Epistaxis, Headache
Clinical narrative: extreme itchiness; Splotches from elbow to shoulder; Pink area on arm/extremly discolored; Elevated blood pressure; condition aggravated; COVID Arm; Nose bleed; Fever; Chills; Headache; Aching muscles; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm) and EPISTAXIS (Nose bleed) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21M and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Cipro), Drug allergy (statins), Hypertension since April 2019, Hypercholesteraemia since April 2019 and Allergy (fiberglass). Concomitant products included EVOLOCUMAB (REPATHA SURECLICK) for Cholesterol, CARVEDILOL, LISINOPRIL, CLOPIDOGREL, ACETYLSALICYLIC ACID (ASPRIN) and CLONIDINE for Hypertension, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Aching muscles) and PAIN IN EXTREMITY (sore arm). On 02-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm), EPISTAXIS (Nose bleed) and RASH (Splotches from elbow to shoulder). On 05-Apr-2021, the patient experienced PRURITUS (extreme itchiness). At the time of the report, VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm), EPISTAXIS (Nose bleed), PRURITUS (extreme itchiness), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Aching muscles) and PAIN IN EXTREMITY (sore arm) had resolved and RASH (Splotches from elbow to shoulder) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Blood pressure measurement: 197/99 mmHg (High) 197/99 at 5 am.         For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) , reporter did not provide any causality assessment.   This case was linked to MOD-2021-108741 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: patient demographics, concomitant medications, medical history, lab values, description of events, treatment information On 29-Jul-2021: NNI FU - No new information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Myalgia, Pain in extremity, Pruritus, Pyrexia
Clinical narrative: extreme itchiness; Splotches from elbow to shoulder; Pink area on arm/extremly discolored; Elevated blood pressure; condition aggravated; COVID Arm; Nose bleed; Fever; Chills; Headache; Aching muscles; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm) and EPISTAXIS (Nose bleed) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21M and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Cipro), Drug allergy (statins), Hypertension since April 2019, Hypercholesteraemia since April 2019 and Allergy (fiberglass). Concomitant products included EVOLOCUMAB (REPATHA SURECLICK) for Cholesterol, CARVEDILOL, LISINOPRIL, CLOPIDOGREL, ACETYLSALICYLIC ACID (ASPRIN) and CLONIDINE for Hypertension, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Aching muscles) and PAIN IN EXTREMITY (sore arm). On 02-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm), EPISTAXIS (Nose bleed) and RASH (Splotches from elbow to shoulder). On 05-Apr-2021, the patient experienced PRURITUS (extreme itchiness). At the time of the report, VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm), EPISTAXIS (Nose bleed), PRURITUS (extreme itchiness), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Aching muscles) and PAIN IN EXTREMITY (sore arm) had resolved and RASH (Splotches from elbow to shoulder) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Blood pressure measurement: 197/99 mmHg (High) 197/99 at 5 am.         For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) , reporter did not provide any causality assessment.   This case was linked to MOD-2021-108741 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: patient demographics, concomitant medications, medical history, lab values, description of events, treatment information On 29-Jul-2021: NNI FU - No new information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site discolouration, Vaccination site reaction
Clinical narrative: extreme itchiness; Splotches from elbow to shoulder; Pink area on arm/extremly discolored; Elevated blood pressure; condition aggravated; COVID Arm; Nose bleed; Fever; Chills; Headache; Aching muscles; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm) and EPISTAXIS (Nose bleed) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21M and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Cipro), Drug allergy (statins), Hypertension since April 2019, Hypercholesteraemia since April 2019 and Allergy (fiberglass). Concomitant products included EVOLOCUMAB (REPATHA SURECLICK) for Cholesterol, CARVEDILOL, LISINOPRIL, CLOPIDOGREL, ACETYLSALICYLIC ACID (ASPRIN) and CLONIDINE for Hypertension, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Aching muscles) and PAIN IN EXTREMITY (sore arm). On 02-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm), EPISTAXIS (Nose bleed) and RASH (Splotches from elbow to shoulder). On 05-Apr-2021, the patient experienced PRURITUS (extreme itchiness). At the time of the report, VACCINATION SITE DISCOLOURATION (Pink area on arm/extremly discolored), HYPERTENSION (Elevated blood pressure), CONDITION AGGRAVATED (condition aggravated), VACCINATION SITE REACTION (COVID Arm), EPISTAXIS (Nose bleed), PRURITUS (extreme itchiness), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Aching muscles) and PAIN IN EXTREMITY (sore arm) had resolved and RASH (Splotches from elbow to shoulder) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Blood pressure measurement: 197/99 mmHg (High) 197/99 at 5 am.         For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) , reporter did not provide any causality assessment.   This case was linked to MOD-2021-108741 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: patient demographics, concomitant medications, medical history, lab values, description of events, treatment information On 29-Jul-2021: NNI FU - No new information was provided.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Pyrexia
Clinical narrative: Felt like I had extra saliva running in mouth; Fatigue; Chills; Headache; Fever; Dry cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough), SALIVARY HYPERSECRETION (Felt like I had extra saliva running in mouth), FATIGUE (Fatigue), CHILLS (Chills) and HEADACHE (Headache) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced COUGH (Dry cough). On 28-Mar-2021, the patient experienced PYREXIA (Fever). On 29-Mar-2021, the patient experienced SALIVARY HYPERSECRETION (Felt like I had extra saliva running in mouth), FATIGUE (Fatigue), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ZINC at an unspecified dose and frequency. On 01-Apr-2021, COUGH (Dry cough), FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) had resolved. At the time of the report, SALIVARY HYPERSECRETION (Felt like I had extra saliva running in mouth) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, SARS-CoV-2 test positive: Positive. On 14-Apr-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (IUnknown), the reporter did not provide any causality assessments.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Salivary hypersecretion
Clinical narrative: Felt like I had extra saliva running in mouth; Fatigue; Chills; Headache; Fever; Dry cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough), SALIVARY HYPERSECRETION (Felt like I had extra saliva running in mouth), FATIGUE (Fatigue), CHILLS (Chills) and HEADACHE (Headache) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced COUGH (Dry cough). On 28-Mar-2021, the patient experienced PYREXIA (Fever). On 29-Mar-2021, the patient experienced SALIVARY HYPERSECRETION (Felt like I had extra saliva running in mouth), FATIGUE (Fatigue), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ZINC at an unspecified dose and frequency. On 01-Apr-2021, COUGH (Dry cough), FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) had resolved. At the time of the report, SALIVARY HYPERSECRETION (Felt like I had extra saliva running in mouth) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, SARS-CoV-2 test positive: Positive. On 14-Apr-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (IUnknown), the reporter did not provide any causality assessments.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Rhinorrhoea
Clinical narrative: Running nose; Pain in legs/Pain in arm; Fever; This spontaneous case was reported by a health care professional and describes the occurrence of RHINORRHOEA (Running nose), PAIN IN EXTREMITY (Pain in legs/Pain in arm) and PYREXIA (Fever) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced RHINORRHOEA (Running nose), PAIN IN EXTREMITY (Pain in legs/Pain in arm) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Running nose), PAIN IN EXTREMITY (Pain in legs/Pain in arm) and PYREXIA (Fever) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient was having running nose, fever, pain in the legs and pain in his arm after receiving his second dose of the Moderna COVID-19 vaccine on yesterday 13 Apr 2021. Symptom started and patient took Tylenol to help with the symptoms. The symptom was still not better and patient had to call off from work. Patient was not on any medication.
Sex: F
Vaccine: COVID19
Symptoms: Bone pain
Clinical narrative: Aches from bones; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Aches from bones) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced BONE PAIN (Aches from bones). At the time of the report, BONE PAIN (Aches from bones) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was asking whether she can take ibuprofen or not.  No concomitant medication information was provided. No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up received on 05-Aug-2021 and contains no new information.
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: Contracted covid after receiving first vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPOSURE TO SARS-COV-2 (Contracted covid after receiving first vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (Contracted covid after receiving first vaccine). At the time of the report, EXPOSURE TO SARS-COV-2 (Contracted covid after receiving first vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: pinkish reaction on arm at both injections; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (pinkish reaction on arm at both injections) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (pinkish reaction on arm at both injections). At the time of the report, INJECTION SITE ERYTHEMA (pinkish reaction on arm at both injections) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment information was provided.